Dr George L Drusano MD is Director, Institute for Therapeutic Innovation of the University of Florida, USA. He is a reviewer for prestigious peer-reviewed journals, including
Science-Translational Medicine, New England Journal of Medicine, the Annals of Internal Medicine, Archives of Internal Medicine, American Journal of Medicine, Journal of Infectious Diseases, the Journal of Antimicrobial Chemotherapy, and Antiviral Research. He was also editor for Antimicrobial Agents and Chemotherapy and is currently an Editor for mBio. He is the author of over 300 articles in peer-reviewed journals. He is a Fellow of the Infectious Diseases Society of America. He has won a number of awards, including being named Distinguished Investigator of the Year (2003) by the American College of Clinical Pharmacology. He was named recipient of the Maxwell Finland Award for Scientific Achievement for 2012 from the National Foundation for Infectious Diseases. He was named the recipient of the Cubist-ICAAC award for 2013 from the American Society for Microbiology. Most recently, he was awarded the Paul Ehrlich Magic Bullet Award in 2015. He is an active researcher, who has attracted many prestigious grant focusing on mathematical modeling and the
pharmacodynamics of anti-infective chemotherapy, especially the pharmacodynamics of anti-tuberculosis agents, MDR/XDR nosocomial pathogens, multiple anti-viral agents and the therapy of biodefense pathogens.